Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparison Between the Effect of Triclosan Toothpaste and Chlorhexidine Mouthwash on Gingival Health in a Group of Fixed Orthodontic Patients: A Randomized Controlled Clinical Trial

5. september 2026 oppdatert av: Fatimah Alzahra Alwane, University of Science and Technology, Yemen

Study Protocol Introduction Title of the research study Comparison Between the effect of Triclosan Toothpaste and chlorhexidine Mouthwash on Gingival Health in Fixed Orthodontic Patients :A randomization controlled clinical trial.

Background Orthodontic brackets and elastics might interfere with effective removal of dental plaque, thereby increasing the risk of gingivitis. The aim of this study to compare the effect of triclosan toothpaste and chlorhexidine mouthwash on gingival health in a group of fixed orthodontic patients.

Procedures Participant eligibility will be assessed based on a dental examination, medical history and inclusion and exclusion criteria.

Inclusion criteria:

  • Patient age 18-35 years old.
  • Orthodontic patient in leveling and alignment stage.
  • Interested, cooperative fixed orthodontic patients who are aware of the importance of using toothpastes and mouthwash during orthodontic treatment.
  • Patients who have good oral hygiene during orthodontic treatment.
  • Medically fit patients who are not using any medical treatment that may affect periodontal health such as (antibiotic, phenytoin).
  • Class I, II, III malocclusion with mild to moderate crowding.

Exclusion criteria:

  • Patients with systemic disease affecting periodontal health such as (lichen planus, pemphigus)
  • Smoker patients.
  • Chewing qat patients. Eligible participants will be randomly assigned to one of three groups Group 1: will use Colgate Total® toothpaste containing sodium fluoride 0.24% and Triclosan 0.3% for one month twice a day.

Group 2: will use Maxfresh ® toothpaste containing sodium fluoride 0.24% in addition to Hexadyl® Chlorhexidine mouthwash for one month twice a day.

Group 3: will brush their teeth by Colgate Maxfresh ® toothpaste containing sodium fluoride 0.24% for 3 month twice a day.

The participant will be instructed to brush and rinse his or her teeth twice a day and they must follow orthodontic treatment instructions to maintain the braces.

The study will last for three month.

Studieoversikt

Detaljert beskrivelse

3.2 Study population The study population will include fixed orthodontic patients who visit the dental clinics in the College of Dentistry, University of Science and Technology, Sana'a University, and private dental clinics. 3.3 Sample size In this study, the sample size will be determined using a power calculation based on a previous study (Alavi et al. 2018). Their study found a significant difference in the dental plaque index between the Chlorhexidine and fluoride groups (0.003±0.06 vs.

0.249±0.21). To achieve a power of 80% and confidence interval of 95%, the study will need to include 7 participants in each group (https://www.openepi.com/SampleSize/SSPropor.htm).To increase the reliability of the study and to make comparisons with previous similar studies, a total of 10 participants will be included in each group. This will result in a total sample of 60 participants in the study.

Triclosan group (10 male, 10 female), CHX group (10 male, 10 female) and Controlled group (10 male, 10 female). 3.4 sample selection 3.4.1 Inclusion criteria:

  • Patient age 18-35 years old.
  • Interested, cooperative fixed orthodontic patients who are aware of the importance of using toothpastes and mouthwash during orthodontic treatment.
  • Patients who have good oral hygiene during orthodontic treatment.
  • Medically fit patients who are not using any medical treatment that may affect periodontal health such as (antibiotic, phenytoin).
  • Class I, II, III malocclusion with mild to moderate crowding. 3.4.2 Exclusion criteria:
  • Patients with systemic disease affecting periodontal health such as (lichen planus, pemphigus)
  • Smoker patients.
  • Chewing qat patients. 3.5 study groups: The participants will be selected according to inclusion &exclusion criteria and they will be divided in to three groups and will be given instructions as follows:
  • Group I (Triclosan group): will brush their teeth by Colgate Total® toothpaste containing sodium fluoride 0.24% and Triclosan 0.3% for 3 month twice a day.
  • Group II (CHX group): will brush their teeth by Colgate maxfresh ® toothpaste containing sodium fluoride 0.24% in addition to Hexadyl® Chlorhexidine mouthwash for 3 month twice a day.
  • Group III (Controlled group): will brush their teeth by Colgate maxfresh ® toothpaste containing sodium fluoride 0.24% for 3 month twice a day. The selected toothpaste and mouthwash will be provided for all participants free of charge.

3.6 Clinical examination, Measurement, procedure: Clinical examination will be performed for Triclosan group and CHX group participants in dental unit. Teeth and gingiva will be dried and examined under adequate light, using a mouth mirror and periodontal probe. Before the beginning of examination, all of the selected participants will be instructed on tooth brushing technique (bass technique) and flossing. Scaling and polishing will be performed 2 weeks prior to the beginning of the study. Patients who will fail to maintain good oral hygiene will be excluded from the study.

The measurement will be done on teeth selected according to the proposal method for plaque index, gingival index. Patients should brush and rinse their teeth twice a day and they must follow orthodontic treatment instructions to maintain their fixed orthodontic appliance. Each patient will be informed to brush twice daily with the assigned toothpaste and will be provided with a follow up chart each visit where the dentist will assess the compliance of the patients. The patients will mark in the follow up chart each time they brush their teeth. 3.6.1 follow up time: To detect a clinically meaningful reduction in plaque index from baseline to 3 months among the study groups (Boneta A, Aguilar M, Romeu F, Stewart B, DeVizio W,

Proskin H.) clinical examination will be in three period of time: Initial examination (T0):

will be performed at the beginning of the study, before orthodontic treatment and after scaling and polishing and oral hygiene instruction. First examination (T1): will be performed 1 month after fixed orthodontic appliance is inserted. Secondary examination (T2): will be performed 2 months after fixed orthodontic appliance is inserted. Final examination(T3): will be performed 3 months after fixed orthodontic appliance is inserted.

3.6 Randomization This study will be a randomized controlled clinical trial design to compare between Triclosan toothpaste and Chlorhexidine mouthwash on gingival health. The sample will be randomly divided into three groups by using the sealed envelope technique to achieve random allocation to the study groups. Each envelope will be numberd from 1 to 60 and papers will be written to be inserted inside the envelope with the name of each group (Triclosan group, CHX group or controlled group) according to the number of samples for each group (20 paper for Triclosan group ,20 paper for CHX group 20 paper for controlled group). Each participant will choose an envelope and the assistant will record each participant's result and keep it in list to know the participants of each group and give each participant the necessary instructions for his/her group. 3.7 Blinding This study will be double-blind study the researcher and statistician will not be able to know who the participants are in each group. There will be a supervisor to help in divide the groups, give instruction, and record the results. participants will be aware of the product being used because it is difficult to hide the toothpaste and mouthwash containers.

This rigorous approach reduces potential biases and enhances the scientific validity of the study.

Studietype

Intervensjonell

Registrering (Faktiske)

60

Fase

  • Fase 4

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Sana'a City
      • Sanaa, Sana'a City, Jemen
        • Faculty of Dentistry

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Patient age 18-35 years old.
  • Interested, cooperative fixed orthodontic patients who are aware of the importance of using toothpastes and mouthwash during orthodontic treatment.
  • Patients who have good oral hygiene during orthodontic treatment.
  • Medically fit patients who are not using any medical treatment that may affect periodontal health such as (antibiotic, phenytoin).
  • Class I, II, III malocclusion with mild to moderate crowding.

Exclusion Criteria:

  • - Patients with systemic disease affecting periodontal health such as (lichen planus, pemphigus)
  • Smoker patients.
  • Chewing qat patients.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Sekvensiell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Triclosan toothpaste with sodium fluoride
participants will brush their teeth twice daily
participant will brush their teeth with triclosan and sodium fluoride toothpaste twice daily
Eksperimentell: CHX Mouthwash Group with sodium fluoride toothpaste
participants will brush and rinsing their teeth twice daily
participant will brush and rinse their teeth with CHX mouthwash and sodium fluoride toothpaste
Aktiv komparator: control Group sodium fluoride toothpaste
participants will brush their teeth twice daily
participant will brush their teeth twice daily

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
gingival index
Tidsramme: at baseline, one month, two months, three months.
evaluation of gingival index using the Loe and Sinless gingival index
at baseline, one month, two months, three months.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
plaque index
Tidsramme: at baseline, one month, two months, three months.
evaluation of dental plaque accumulation using Loe and Sinless plaque index
at baseline, one month, two months, three months.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

14. februar 2026

Primær fullføring (Faktiske)

9. mai 2026

Studiet fullført (Faktiske)

9. august 2026

Datoer for studieregistrering

Først innsendt

5. september 2026

Først innsendt som oppfylte QC-kriteriene

5. september 2026

Først lagt ut (Faktiske)

11. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

individual participant data will not be shared to protect patient privacy and confidentiality

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere